Publication | Open Access
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
1.2K
Citations
28
References
2012
Year
ImmunologyClinical TrialsNeurological ProgressDisease-modifying TherapyMultiple SclerosisMedicineNovel Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1